These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

605 related items for PubMed ID: 24980139

  • 1. Key advances in the clinical approach to ANCA-associated vasculitis.
    Kallenberg CG.
    Nat Rev Rheumatol; 2014 Aug; 10(8):484-93. PubMed ID: 24980139
    [Abstract] [Full Text] [Related]

  • 2. ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.
    Cornec D, Cornec-Le Gall E, Fervenza FC, Specks U.
    Nat Rev Rheumatol; 2016 Oct; 12(10):570-9. PubMed ID: 27464484
    [Abstract] [Full Text] [Related]

  • 3. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J, Kim HJ, Ahn SS, Jung SM, Song JJ, Park YB, Lee SW.
    Clin Exp Rheumatol; 2017 Oct; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [Abstract] [Full Text] [Related]

  • 4. Current and emerging techniques for ANCA detection in vasculitis.
    Csernok E, Moosig F.
    Nat Rev Rheumatol; 2014 Aug; 10(8):494-501. PubMed ID: 24890776
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S, Villarreal M, Miloslavsky EM, Lu N, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CM, St Clair EW, Ikle D, Tchao NK, Ding L, Brunetta P, Choi HK, Monach PA, Fervenza F, Stone JH, Specks U, RAVE-ITN Research Group.
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. ANCA associated vasculitis (AAV): a review for internists.
    Yaseen K, Mandell BF.
    Postgrad Med; 2023 Jan; 135(sup1):3-13. PubMed ID: 35831990
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. ANCA-Associated Vasculitis: Core Curriculum 2020.
    Geetha D, Jefferson JA.
    Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Optimal management of ANCA-associated vasculitis before and during pregnancy: current perspectives.
    Pecher AC, Henes M, Henes JC.
    Arch Gynecol Obstet; 2023 Aug; 308(2):379-385. PubMed ID: 36104505
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management.
    Trivioli G, Marquez A, Martorana D, Tesi M, Kronbichler A, Lyons PA, Vaglio A.
    Nat Rev Rheumatol; 2022 Oct; 18(10):559-574. PubMed ID: 36109667
    [Abstract] [Full Text] [Related]

  • 16. Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis.
    Walker BS, Peterson LK, Koening C, White SK, Schmidt RL, Tebo AE.
    Autoimmun Rev; 2022 Jun; 21(6):103100. PubMed ID: 35452854
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides.
    Wójcik K, Masiak A, Jeleniewicz R, Jakuszko K, Brzosko I, Storoniak H, Kur-Zalewska J, Wisłowska M, Madej M, Hawrot-Kawecka A, Głuszko P, Kucharz EJ, Polvas Consortium.
    Pol Arch Intern Med; 2022 Mar 30; 132(3):. PubMed ID: 34985235
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.